Skip to main content

Day: January 10, 2022

Mettler-Toledo International Inc. to Host Fourth Quarter 2021 Earnings Conference Call

COLUMBUS, Ohio, Jan. 10, 2022 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced it will host a conference call to discuss the Company’s quarterly results on Thursday, February 10, 2022 at 5:00 p.m. Eastern Time. To hear a live webcast of the call, visit www.mt.com/investors on the Company’s website. A replay of the webcast will be available until February 14, 2022.         METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including...

Continue reading

Accolade Announces Results for Fiscal Third Quarter 2022 

Fiscal third quarter 2022 revenue of $83.5 million, a 117% increase compared to fiscal third quarter 2021 revenue of $38.4 million  Company introduces preliminary guidance for fiscal year 2023, expecting 25% growth in revenue and a reduction in Adjusted EBITDA loss Initial Accolade One and Accolade Care customers launched on January 1, 2022SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2021. “It is remarkable for me to look back at the last twelve months and consider Accolade’s transformation from a navigation and advocacy company to a personalized healthcare company. In January 2021, we were serving about 100 customers and 2 million members. Today, with the integration of primary care, mental health and expert medical...

Continue reading

CapStar Announces Date for Fourth Quarter 2021 Earnings Release and Conference Call

NASHVILLE, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ: CSTR) announced today that it will issue its fourth quarter 2021 earnings release after the market closes on January 27, 2022. CapStar will also host a conference call and webcast at 9:00 a.m. Central Time on Friday, January 28, 2022 to discuss its financial results. Analysts and investors may participate in the question-and-answer session. Conference Call and Webcast Information: Date: Friday, January 28, 2022Time: 9:00 a.m. Central TimeTelephone Access: (844) 412-1002; Conference ID: 2095058 Webcast Access: A live webcast will be available on CapStar’s website at ir.capstarbank.com. An archived version of the webcast will be available in the same location shortly after the live call has ended. About CapStar Financial Holdings,...

Continue reading

Diamondback Energy, Inc. Schedules Fourth Quarter 2021 Conference Call for February 23, 2022

MIDLAND, Texas, Jan. 10, 2022 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2021 financial results on February 22, 2022 after the market closes. In connection with the earnings release, Diamondback will host a conference call and webcast for investors and analysts to discuss its results for the fourth quarter of 2021 on Wednesday, February 23, 2022 at 8:00 a.m. CT. Participants should call (877) 440-7573 (United States/Canada) or (253) 237-1144 (International) and use the confirmation code 8984419. A telephonic replay will be available from 11:00 a.m. CT on Wednesday, February 23, 2022, through Wednesday, March 2, 2022 at 11:00 a.m. CT. To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406 (International) and enter...

Continue reading

electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine

ROCKAWAY, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper, entitled “Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial” in Cephalalgia, the official journal of the International Headache Society (IHS). The paper reports the results of a randomized, double-blind, sham-controlled trial conducted at twenty-seven sites across the United States. Originally designed and powered to randomize 400 patients, the study was closed early due to COVID-19 after enrolling 231 subjects. The results of the study showed a decrease in the number of monthly headache days of 4.6 vs. -3.0 for sham (p=0.05) with 44.87% of subjects...

Continue reading

Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2021 Conference Call for February 24, 2022

MIDLAND, Texas, Jan. 10, 2022 (GLOBE NEWSWIRE) — Rattler Midstream LP (NASDAQ: RTLR) (“Rattler”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2021 financial results on February 23, 2022 after the market closes. In connection with the earnings release, Rattler will host a conference call and webcast for investors and analysts to discuss its results for the fourth quarter of 2021 on Thursday, February 24, 2022 at 9:00 a.m. CT. Participants should call (877) 288-2756 (United States/Canada) or (470) 495-9481 (International) and use the confirmation code 2297026. A telephonic replay will be available from 12:00 p.m. CT on Thursday, February 24, 2022 through Thursday, March 3, 2022 at 12:00 p.m. CT. To access the replay, call (855) 859-2056 (United States/Canada)...

Continue reading

Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2021 Conference Call for February 23, 2022

MIDLAND, Texas, Jan. 10, 2022 (GLOBE NEWSWIRE) — Viper Energy Partners LP (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2021 financial results on February 22, 2022 after the market closes. In connection with the earnings release, Viper will host a conference call and webcast for investors and analysts to discuss its results for the fourth quarter of 2021 on Wednesday, February 23, 2022 at 10:00 a.m. CT. Participants should call (844) 400-1537 (United States/Canada) or (703) 326-5198 (International) and use the confirmation code 5529768. A telephonic replay will be available from 1:00 p.m. CT on Wednesday, February 23, 2022, through Wednesday, March 2, 2022 at 1:00 p.m. CT. To access the replay, call (855) 859-2056 (United...

Continue reading

STRATA Skin Sciences Announces Acquisition of Acne Treatment Device Assets from Theravant Corporation

Substantially broadens STRATA’s opportunity for expansion potential into the estimated $5.5 billion acne care marketLeverages STRATA’s innovative marketing platform, commercial team and worldwide distributor network to drive additional revenue growthCreates a robust pipeline of new opportunities, targeting dermatologic conditions beyond acne, with a unique treatment approachEstablishes STRATA’s position as a global leader of clinical dermatology devicesHORSHAM, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it has entered into a definitive agreement to acquire assets related to Theravant Corporation’s TheraClear System. Theravant...

Continue reading

Skeljungur hf.: Updated Financial Calendar

Skeljungur’s updated Financial Calendar for 2022 below. Please note the amended dates for Q4 2021 results and the 2022 Annual General Meeting: Q4 2021 results and annual report year 2021: February 8, 2022 Annual General Meeting 2022: March 10, 2022 Q1 2022: April 28, 2022 Q2 2022: August 11, 2022 Q3 2022: October 27, 2022 Q4 2022 results and annual report year 2022: February 7, 2023 Annual General Meeting 2023: March 9, 2023 The publication of the financial results will take place after the market have closed. Please note that this calendar may be subject to change. For further information please contact Árni Pétur Jónsson, CEO, investors@skeljungur.is  

Continue reading

Proofpoint Completes the Acquisition of Dathena; Strengthens Enterprise Information Protection Offering

The combined solution will solve legacy endpoint data loss prevention challenges and deliver real security value through detection, response, and compliance SUNNYVALE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Proofpoint, Inc., a leading cybersecurity and compliance company, today announced it has completed its acquisition of Dathena, an innovator in artificial intelligence-powered data protection. With this acquisition, Proofpoint strengthens its cloud-based people-centric security solutions by adding AI-based data classification to its Information & Cloud Security platform, helping organizations to better understand information risk and help to eliminate data loss in today’s hybrid world. “Data doesn’t lose itself. People lose data, and organizations are increasingly adopting data loss prevention strategies to manage that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.